Design and colour combination deemed ‘too common’ in the pharma sector for protection | Court says trademarks must be ...

Court delivers default judgment dismissing EOFlow’s patent revocation claim | Dispute escalates following EOFlow’s refusal to ...

Court of Appeal backs Astellas in UK patent fight over prostate cancer drug | Generics’ challenge fails as judges warn on ...

$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues. Already ...

27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Non-profit alleges that Humira pricing displaced essential healthcare, violated EU competition law and breached human rights | Court notes ‘social significance’ of case—but this can’t translate into ...

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...